CClinicalTrials.gg
Status unknownNCT00609570Updated Oct 28, 2008

Nutritional Supplements on Blood Pressure 2008

A Phase 1 interventional study of NanoGreens and Whey protein in Hypertension, sponsored by Logan College of Chiropractic. Status unknown at 2 sites in United States. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2008-10-28.

Sponsored by Logan College of Chiropractic · Phase 1, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2008), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 1
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 70 Years
Sex
All
01

Study summary

Three different supplements will be used in the study (fruits and vegetable powders, whey protein and calcium) for patients with hypertension. The null hypothesis was that the supplements had no effects on participants' blood pressure.

Read the detailed description

Hypertensive participants will be randomly assigned into three groups. The first group of participants will take the fruits and vegetable powders mixed with water. The second group takes whey protein and the third group takes calcium pills. Blood pressure and heart rate variability will be measured every two weeks for three months.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • hypertension
  • supplement
  • HRV
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's planned enrollment of 60 is below the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Logan College of Chiropractic is the lead sponsor of 48 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 20-70
  • Hypertensive male and female subjects.

Exclusion criteria

Exclusion Criteria:

  • Severe cardiovascular and renal conditions.
  • Pregnancies and taking medications.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Fruit and vegetables

    Fruits and vegetables

    Dietary Supplement: NanoGreens

  • Active comparator
    Whey protein

    Whey protein

    Dietary Supplement: Whey protein

  • Active comparator
    Ca

    Calcium pills

    Dietary Supplement: Calcium pills

Interventions

  • Dietary supplementNanoGreens

    fruits and vegetables

  • Dietary supplementWhey protein

    Whey

    Also known as: NanoPro

  • Dietary supplementCalcium pills

    CA

    Also known as: CA

06

What researchers measure

Primary outcomes

  1. Blood pressure and HRV

    Time frame: every two weeks for three months

07

Study locations

1 of 2 sites recruiting
  • Logan University, College of Chiropractic
    Chesterfield, Missouri 63006, United States
    Recruiting
  • Logan University
    Chesterfield, Missouri 63017, United States
    Not yet recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 28, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00609570
Lead sponsor
Logan College of Chiropractic
First posted
Feb 7, 2008
Start date
Oct 2008
Primary completion
Jul 2009 (estimated)
Completion
Jul 2009 (estimated)
Last update
Oct 28, 2008

Study contacts

John Zhang, MD PhD
Contact
john.zhang@logan.edu
636 230 1920
John Zhang, MD, PhD
study chair · Logan University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion